173 related articles for article (PubMed ID: 12837675)
1. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease.
Lu CJ; Tune LE
Am J Geriatr Psychiatry; 2003; 11(4):458-61. PubMed ID: 12837675
[TBL] [Abstract][Full Text] [Related]
2. Donepezil for Down's syndrome.
Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
[No Abstract] [Full Text] [Related]
3. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report.
Miyaoka T; Seno H; Yamamori C; Inagaki T; Itoga M; Tsubouchi K; Horiguchi J
J Clin Psychiatry; 2001 Jul; 62(7):573-4. PubMed ID: 11488374
[No Abstract] [Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
5. Use of anticholinergic medications by older adults with dementia.
Roe CM; Anderson MJ; Spivack B
J Am Geriatr Soc; 2002 May; 50(5):836-42. PubMed ID: 12028169
[TBL] [Abstract][Full Text] [Related]
6. Behavioral complications associated with donepezil.
Wengel SP; Roccaforte WH; Burke WJ; Bayer BL; McNeilly DP; Knop D
Am J Psychiatry; 1998 Nov; 155(11):1632-3. PubMed ID: 9812142
[No Abstract] [Full Text] [Related]
7. Abnormal movements with donepezil in Alzheimer disease.
Amouyal-Barkate K; Bagheri-Charabiani H; Montastruc JL; Moulias S; Vellas B
Ann Pharmacother; 2000 Nov; 34(11):1347. PubMed ID: 11098352
[No Abstract] [Full Text] [Related]
8. Donepezil treatment in Alzheimer's disease patients with and without cerebrovascular lesions: a preliminary report.
Na HR; Kim S; Choi SH; Yang DW; Bae HJ; Kim JE; Park MY; Shim YS; Kim BK; Kwon JC; Yoo BG; Kim BC; Lee JS
Geriatr Gerontol Int; 2011 Jan; 11(1):90-7. PubMed ID: 20825496
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
10. [Acetylcholinesterase inhibitor. Helpful not just in Alzheimer dementia].
MMW Fortschr Med; 2002 Aug; 144(33-34):59. PubMed ID: 12380156
[No Abstract] [Full Text] [Related]
11. A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study.
Arai H; Takahashi T
Am J Geriatr Psychiatry; 2009 Apr; 17(4):353-4. PubMed ID: 19307864
[No Abstract] [Full Text] [Related]
12. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M
Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966
[TBL] [Abstract][Full Text] [Related]
13. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
[TBL] [Abstract][Full Text] [Related]
14. Violent behavior-associated with donepezil.
Bouman WP; Pinner G
Am J Psychiatry; 1998 Nov; 155(11):1626-7. PubMed ID: 9812132
[No Abstract] [Full Text] [Related]
15. Questions about donepezil.
Elie LM; Cole MG
CMAJ; 1998 Apr; 158(8):1014-5. PubMed ID: 9580729
[No Abstract] [Full Text] [Related]
16. Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia.
Hegerl U; Mergl R; Henkel V; Gallinat J; Kotter G; Müller-Siecheneder F; Pogarell O; Juckel G; Schröter A; Bahra R; Emir B; Laux G; Möller HJ
J Clin Psychopharmacol; 2003 Apr; 23(2):214-6. PubMed ID: 12640228
[No Abstract] [Full Text] [Related]
17. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
[TBL] [Abstract][Full Text] [Related]
18. Do extrapyramidal features in Alzheimer patients treated with acetylcholinesterase inhibitors predict disease progression?
Brodaty H; Sachdev P; Berman K; Gibson L; Kemp NM; Cullen B; Burns A
Aging Ment Health; 2007 Jul; 11(4):451-6. PubMed ID: 17612809
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
Crowell TA; Paramadevan J; Abdullah L; Mullan M
J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
[TBL] [Abstract][Full Text] [Related]
20. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
